A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors

NCT05924906 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: NB002

Sponsor

Suzhou Neologics Bioscience Co., Ltd.